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Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations
Short Title: TCR deficiency in CD30+ lymphoproliferations
While the transforming properties of ALK overexpression have been clearly demonstrated [6, 7] , the transformation mechanisms in ALK -sALCL and primary cutaneous CD30 + LPD are poorly understood. CD30 itself, a cytokine receptor belonging to the tumor necrosis factor receptor superfamily, has been a research focus over the past years, but whether CD30 signaling leads to cell cycle arrest, apoptosis or even proliferation in CD30 + lymphoproliferations is still a matter of debate [8] [9] [10] [11] .
We could previously show that a unifying molecular defect in ALCL, regardless of their ALK-expression status, is a TCR and CD3% expression deficiency, which -in most cases -was associated with a lost or markedly reduced expression of ZAP-70 [1] . The aim of the present study was three-fold; first, we wished to expand the investigation of TCR-associated molecules in sALCL including the expression of the entire TCR/CD3 complex (i.e. all different CD3 molecules), transcription factors responsible for the TCR expression (ATF-1, ATF-2, TCF-1, TCF-1!/LEF-1, and Ets-1) as well as key molecules involved in the signaling of the TCR/CD3 complex (LAT, 4 ZAP70, Syk, Lck, bcl-10, Carma1, and the transcription factors NFATc1, c-Jun, cFos). Second, we included primary cutaneous CD30 + LPD in our study, since virtually nothing is known about the expression of these molecules in these lymphoproliferations. Finally, we aimed at the identification of differentially expressed markers that might be of help in the routine setting in the differential diagnosis of sALCL and primary cutaneous CD30 + LPD, but also between CD30 + T-cell proliferations and peripheral T-cell lymphomas, not otherwise specified (PTCL-NOS).
Design and Methods
Characteristics of the study set
We analyzed paraffin embedded lymph node or skin biopsies from 38 ALK -sALCL, T.R., A.R., E.G.) and cases without consensus were excluded from the study.
Immunohistochemical analyses
Using conventional immunohistochemical single stains, we investigated the expression of CD30 and ALK, as well as the expression of the TCR!/" ("F1) and 
Statistics
Based on approximately equal variances of expression values between different entities, statistical analysis was done using the Wilcoxin-Mann-Whitney two-sample rank-sum test. P-values <0.05 were considered statistically significant.
Results
Immunohistochemical analyses of the TCR/CD3 complex
Since a functional TCR/CD3 complex is composed of a heterodimeric TCR (either !/" or #/$) and three dimers of the four CD3 subunits (#, $ , %, &), we performed immunohistochemical stainings for all of these components, except for the #/$-TCR, since the respective antibody is not applicable to paraffin embedded tissue. Based on the established idea that the TCR/CD3 complex can only be assembled and transported to the cell membrane, when all components consist of correctly folded proteins, we expected a membranous staining pattern for all or none of the proteins.
Interestingly, we could detect a weak to moderate cytoplasmic staining or a pattern, sometimes with a strong staining, restricted to the Golgi complex/endoplasmic reticulum for various combinations of the five molecules, which is likely due to a prolonged degradation process. Surprisingly, we could detect a clear, but 
Immunohistochemical analyses of transcription factors regulating the TCR expression
We next investigated five transcriptions factors known to be involved in the regulation of the expression of the four different TCR-chains. As detailed in Table 2, Characteristic stains for the transcription factors can be viewed in Figure 3 .
Immunohistochemical analyses of key molecules involved in the TCR/CD3 complex signaling cascades
Analyzing key molecules involved in the signal transduction of the TCR/CD3 complex, we could identify a significant reduction of the expression levels of LAT, ZAP-70, and NFATc1 in systemic and cutaneous CD30 + LP compared to PTCL-NOS cases, whereas bcl10 and Carma1 expression revealed no significant differences. Moreover, we could detect a slight but significant difference between the cutaneous and systemic CD30 + LP, the former harbouring a higher percentage of Lck positive cases. As for the transcription factors c-Jun and c-Fos, there was an increased expression in the whole group of CD30 + LP compared to PTCL-NOS. Table 2 summarizes these results and characteristic immunohistochemical stains are depicted in Figure 4 . The complete raw data including the results of all stains in all cases are provided in the Supplementary Table 1 .
Discussion
The results of our study add more details to the disturbance of the TCR/CD3 complex and associated signaling molecules in sALCL and expand these observations to the group of primary cutaneous CD30 + LPD.
A functional TCR/CD3 complex is crucial for T-cell development, as well as for the activation and differentiation of mature T-cells. It is well known, that the TCR!"
heterodimer is noncovalently associated with three dimers formed by the four different CD3 chains ($%, #%, &&). There is an obligatory coexpression of the TCR with the CD3 molecules, while the absence of any single subunit results in a loss of surface expression of the whole complex, and the expressed chains are retained in the endoplasmic reticulum (ER) or Golgi complex and degraded (for review see [12] [13] [14] ).
We were surprised that our immunohistochemical stainings for all four different CD3- and TCR$ genes. In addition, the CD3%, CD4 and IL-2 genes are presumed target genes of TCF-1, CD4 and Lck of Ets-1 and CD4 and CD3% of TCF-1!/LEF-1(for review see [15, 19] ). Since we could not detect a clear-cut correlation when comparing the expression of these transcription factors with that of their target genes, it is unlikely that a transcriptional malfunction is the primary cause of the disturbed TCR/CD3 complex expression.
We next asked the question whether the expression of key molecules of the TCR/CD3 complex associated intracellular signaling cascades (for review see [20] [21] [22] ) is also altered. As a major finding in our study, although briefly mentioned in a previous paper including a small number of T-cell lymphomas [23] , Lck protein expression was almost completely abrogated in sALCL and in more than half of the primary cutaneous CD30 + LPD, whereas all PTCL-NOS showed expression of Lck.
In normal T-cells, Lck, a src kinase, is the first intracellular signaling molecule that is being activated following TCR ligation [22, 24] . Why Lck is not expressed in sALCL tumor cells that lack expression of the TCR/CD3 complex anyway, is unclear.
Perhaps, loss of Lck expression represents just a bystander phenomenon or 'collateral damage' in a tumor cell in which TCR/CD3 complex associated signaling is malfunctioning. Alternatively, loss of Lck expression might provide an additional growth advantage to the tumor cells independent from TCR signaling, e.g. by the abrogation of proapoptotic properties of Lck under specific circumstances [25] .
In a previous report, we had already demonstrated a loss of ZAP-70 [22, 26] expression in the majority of sALCL [1] . Interestingly, the primary cutaneous CD30 
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Fos might be of help in cases, in which staining for the CD3 subunits is inconclusive, although no single marker is able to make a robust distinction.
In conclusion, our results shed further light on the disturbance of the TCR/CD3 complex, associated signaling cascades and transcription factors in sALCL, which appears to parallel the situation in classical Hodgkin lymphoma that usually lack the expression of a B-cell receptor and other characteristic B-cell markers (for review see [39, 40] 
